12-13-2019, 02:28 PM
Finally pulled the plug and sold out of Gilead Sciences (GILD).
Used the proceeds to initiate a position in Bristol-Meyers Squibb (BMY), which recently announced a 10% dividend raise and is projected to have some nice growth in the coming years following the closing of the Celgene acquisition.
Used the proceeds to initiate a position in Bristol-Meyers Squibb (BMY), which recently announced a 10% dividend raise and is projected to have some nice growth in the coming years following the closing of the Celgene acquisition.